Pekka Anttila, Myelooman hoito

Figure 1. Overall survival from
time of relapse after ASCT.
(A)
The Kaplan-Meier curves for overall
survival from the time of
posttransplantation relapse. The
patients are grouped into 2-year
intervals based on the date of
relapse.
(B)
The Kaplan-Meier curves for the
overall survival from the time of
posttransplantation relapse grouped
by whether they were treated
subsequently with one or more of
the newer drugs(thalidomide,
bortezomib, or lenalidomide).
Survival curves were compared
usinglog-rank test.
387 patients